These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 7366683

  • 1. Vasodilator therapy for pulmonary hypertension.
    Cotter L, Honey M.
    N Engl J Med; 1980 May 29; 302(22):1260. PubMed ID: 7366683
    [No Abstract] [Full Text] [Related]

  • 2. Diazoxide in primary pulmonary hypertension.
    Klinke WP, Gilbert JA.
    N Engl J Med; 1980 Jan 10; 302(2):91-2. PubMed ID: 7350437
    [No Abstract] [Full Text] [Related]

  • 3. Hope in primary pulmonary hypertension.
    Reeves JT.
    N Engl J Med; 1980 Jan 10; 302(2):112-3. PubMed ID: 7350416
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy.
    Yildizdas D, Erdem S, Küçükosmanoglu O, Yilmaz M, Yüksel B.
    Adv Ther; 2008 May 10; 25(5):515-9. PubMed ID: 18512033
    [Abstract] [Full Text] [Related]

  • 6. Vasodilator treatment of primary pulmonary hypertension.
    Cotter L.
    Adv Exp Med Biol; 1984 May 10; 164():359-68. PubMed ID: 6695579
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.
    Honey M, Cotter L, Davies N, Denison D.
    Thorax; 1980 Apr 10; 35(4):269-76. PubMed ID: 7434268
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of diazoxide. (Hyperstat I.V.).
    JAMA; 1973 Jun 04; 224(10):1422-3. PubMed ID: 4739994
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Vasodilators, modern therapeutic approach in pulmonary arterial hypertension].
    Gherasim L, Bogdan M.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982 Jun 04; 34(2):97-102. PubMed ID: 6127777
    [No Abstract] [Full Text] [Related]

  • 14. [Oral diazoxide in acute arterial hypertension. Preliminary report].
    Queiroz FP.
    AMB Rev Assoc Med Bras; 1975 Oct 04; 21(10):293-4. PubMed ID: 1082153
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Injectable diazoxide in the treatment of arterial hypertension: its effects on nephroparenchymal hypertension and "accelerated" hypertension].
    Cecchettin M, Maiorca R.
    Clin Ter; 1978 Oct 15; 87(1):45-9. PubMed ID: 737979
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diazoxide.
    Throne ML.
    J Med Assoc Ga; 1973 Nov 15; 62(11):390-1. PubMed ID: 4760620
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protein binding and vascular activity of diazoxide.
    Sellers EM, Koch-Weser J.
    N Engl J Med; 1969 Nov 20; 281(21):1141-5. PubMed ID: 5347827
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.